Status:
ACTIVE_NOT_RECRUITING
Patient-reported Outcomes After Percutaneous Coronary Intervention
Lead Sponsor:
Haukeland University Hospital
Collaborating Sponsors:
Helse Stavanger HF
Oslo University Hospital
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
The main objective is to investigate i) continuity of care, ii) health literacy and self-management, iii) adherence to treatment, and iv) patient preferences, healthcare utilization and costs, and to ...
Detailed Description
CONCARD will use multiple designs. (1) An inductive exploratory design including in-depth interviews on patients' experiences of healthcare delivery will provide a context for the quantitative data to...
Eligibility Criteria
Inclusion
- Patients undergoing percutaneous coronary intervention
- ≥ 18 years of age
- Living at home at the time of inclusion.
Exclusion
- Patients who do not speak Norwegian/Danish
- Patients who are unable to fill in the questionnaires due to reduced capacities
- Institutionalized patients
- Patients with expected lifetime less than one year
- Percutaneous coronary intervention without stent implantation
- Patients undergoing percutaneous coronary intervention related to Transcatheter Aortic Valve Implantation or Mitraclip examination
- Previous enrollment in CONCARD (readmissions).
Key Trial Info
Start Date :
June 12 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2030
Estimated Enrollment :
3417 Patients enrolled
Trial Details
Trial ID
NCT03810612
Start Date
June 12 2017
End Date
May 1 2030
Last Update
February 23 2024
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Herlev and Gentofte Hospital
Copenhagen, Denmark, 1092
2
Rigshospitalet, Copenhagen
Copenhagen, Denmark, 2100
3
Odense University Hospital
Odense, Denmark, 5000
4
Zealand University Hospital
Roskilde, Denmark, 4000